Clinical Trial Update: Re-radiotherapy Combined With Chidamide for the Treatment of Recurrent Head and Neck Squamous Cell Carcinoma After Radiotherapy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating re-radiotherapy combined with chidamide for recurrent head and neck squamous cell carcinoma after prior radiotherapy; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Chidamide (chidamide)

Snippet

Sponsor: West China Hospital | Conditions: Head and Neck Squamous Cell Carcinoma HNSCC | Phase 1 | Status: NOT_YET_RECRUITING